Protocol ID

Official Title

Principal Investigator

Lead CRC

Disease Site

Phase

MK-7902-009

ClinicalTrials.gov #

NCT04428151

A Phase 2 study of lenvatinib (E7080/MK-7902) with or without pembrolizumab (MK-3475) and SOC chemotherapy for R/M HNSCC after platinum therapy and immunotherapy

Dr. Achuta Guddati

Ashlyn Stevenson

Head and Neck Squamous Cell Carcinoma

II

RTOG-1216

ClinicalTrials.gov #

NCT01810913

Randomized Phase I/III Trials of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

Dr. Sharad Ghamande

Inquiries

Head and Neck Squamous Cell Cancer

II/III